Trademark: 87052637
Word
BREELIB
Status Date
Tuesday, February 6, 2018
Registration Number
5393952
Registration Date
Tuesday, February 6, 2018
Filing Date
Friday, May 27, 2016
Published for Opposition
Tuesday, January 10, 2017
5 pharmaceutical preparations for treating pulmonary arterial hypertension via nebulization
10 medical instruments, namely, a nebulzer for treating pulmonary arterial hypertension
The mark consists of the wording "Breelib" in stylized font.
Color is not claimed as a feature of the mark.
The wording "Breelib" has no meaning in a foreign language.
Feb 6, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 6, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 6, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 6, 2018
Registered-Principal Register
Jan 2, 2018
1(B) Basis Deleted; Proceed To Registration
Dec 15, 2017
Notice Of Allowance Cancelled
Jan 2, 2018
Case Assigned To Intent To Use Paralegal
Dec 15, 2017
Teas Delete 1(B) Basis Received
Jul 4, 2017
Noa E-Mailed - Sou Required From Applicant
May 24, 2017
Extension Of Time To Oppose Process - Terminated
May 17, 2017
Changes/Corrections After Pub Approval Entered
May 15, 2017
Assigned To Petition Staff
May 8, 2017
Teas Post Publication Amendment Received
Jan 10, 2017
Extension Of Time To Oppose Received
Jan 10, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 10, 2017
Published For Opposition
Dec 21, 2016
Notification Of Notice Of Publication E-Mailed
Dec 8, 2016
Law Office Publication Review Completed
Nov 30, 2016
Approved For Pub - Principal Register
Nov 23, 2016
Teas/Email Correspondence Entered
Nov 23, 2016
Correspondence Received In Law Office
Nov 22, 2016
Assigned To Lie
Nov 3, 2016
Teas Response To Suspension Inquiry Received
Sep 14, 2016
Notification Of Letter Of Suspension E-Mailed
Sep 14, 2016
Letter Of Suspension E-Mailed
Sep 14, 2016
Suspension Letter Written
Sep 8, 2016
Assigned To Examiner
Jun 6, 2016
New Application Office Supplied Data Entered
May 31, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
